SS-31 Peptide (Elamipretide): Dosage, Protocol, Reconstitution, and Mitochondrial Health Guide
SS-31 (Elamipretide)
SS-31 is a mitochondria-targeted peptide that binds to cardiolipin in the inner mitochondrial membrane, improving ATP production and reducing oxidative stress. Unlike hormonal peptides, it works directly at the cellular energy level.
How SS-31 Works
Mitochondria Targeting → Cardiolipin Stabilization → ATP ↑ → ROS ↓ → Cellular Energy ↑
SS-31 stabilizes mitochondrial membranes and improves electron transport efficiency. This leads to increased ATP production, reduced oxidative damage, and improved cellular resilience.
Standard / Practical Protocol
10 mg vial + 1.0 mL BAC Water → 1 unit = 0.1 mg → Practical Real-World Mitochondrial Support
Standard Setup
Vial10 mg
Water1.0 mL bacteriostatic water
Concentration10 mg/mL
Conversion1 unit = 0.1 mg
Weeks 1–2
Loading
Dose5 mg daily
Units50 units
Volume0.50 mL
Weeks 3–8
Standard Range
Dose10–20 mg daily
Units100–200 units
Volume1.0–2.0 mL
Why use this version?
Practical Approach
This is the practical real-world approach. It keeps the math simple and reflects the dose range most commonly discussed for balancing cost and effectiveness.
What to Expect
Effects may begin within 1–2 weeks, but consistency matters more than exact clock timing with SS-31.
Advanced / Aggressive Protocol
10 mg vial + 1.0 mL BAC Water → 1 unit = 0.1 mg → Higher Exposure for More Aggressive Mitochondrial Support
Advanced / Aggressive Setup
Vial10 mg
Water1.0 mL bacteriostatic water
Concentration10 mg/mL
Conversion1 unit = 0.1 mg
Weeks 1–2
Loading
Daily Dose5 mg
Units50 units
Volume0.50 mL
Weeks 3–4
Build
Daily Dose10 mg
Units100 units
Volume1.0 mL
Weeks 5–8
Aggressive Range
Daily Dose15 mg
UnitsSplit: 2 × 75 units
Volume2 × 0.75 mL
Optional Weeks 9–12
Top-End Range
Daily Dose20 mg
UnitsSplit: 2 × 100 units
Volume2 × 1.0 mL
Why split at higher doses?
Comfort & Practicality
Once SS-31 reaches higher daily amounts, splitting the total into two injections is usually more practical for comfort and absorption.
Real-World Limitation
Higher-dose use is more limited by cost and injection volume than by simple math.
How to Use SS-31 (Cycle, Timing & Injection)
Cycle Length4–12 weeks
Break Between Cycles2–4 weeks off
Injection TypeSubcutaneous
Common SitesAbdomen, thigh, or upper arm
Best Time to Take
Any consistent time can work
Standard protocols are often once daily
Higher-dose protocols may use split AM / PM timing
Consistency matters more than exact clock timing with SS-31
Where to Inject
Abdomen, thigh, or upper arm
Rotate injection sites regularly
At higher daily amounts, split injections can improve practicality
When to Use
During mitochondrial support phases
During energy, fatigue, or endurance-focused phases
Alongside recovery or metabolic support strategies
As a structured support phase rather than indefinite daily use
Simple Strategy
Practical Range
Most people stay in the 5–20 mg range because it is more practical for cost and injection volume.
Use Goal
SS-31 is usually best run with a clear mitochondrial or recovery-support goal, then paused once that phase ends.
Real-World vs Clinical Dosing
Low Dose → Mild Effect → Moderate Dose → Strong Effect → High Dose → Full Mitochondrial Support
Real-World vs Clinical Context
5–10 mgEntry-level mitochondrial support
10–20 mgBest balance of cost and effectiveness
30–40 mgClinical-level dosing where strongest outcomes are discussed
Simple takeaway:
Lower doses may provide partial support, while higher doses are often discussed as producing stronger mitochondrial stabilization. Most people stay in the 5–20 mg range because it is more practical.
Lower doses may provide partial support, while higher doses are often discussed as producing stronger mitochondrial stabilization. Most people stay in the 5–20 mg range because it is more practical.
Why SS-31 Often Requires Higher Dosing
Why the dose can look higher
SS-31 works differently than most peptides. Instead of acting on a surface receptor, it must circulate, enter cells, and reach mitochondria.
Because of this, the dose is not about creating a quick signal. It is about getting enough peptide to the exact place where it needs to work.
At each step — bloodstream, tissues, cells, and finally mitochondria — only a portion reaches the final target.
This is why the amount can appear higher compared to peptides that only need to trigger a receptor.
SS-31 supports mitochondrial structure and energy function rather than creating a short temporary signal.
Reconstitution & Dosing (10 mg Vial)
Reconstitution & Dosing
Vial10 mg
Water1.0 mL bacteriostatic
Concentration10 mg/mL
Conversion1 unit = 0.1 mg
Dose Reference
50 units = 5 mg
75 units = 7.5 mg
100 units = 10 mg
150 units = 15 mg
200 units = 20 mg
Reconstitution Steps
Draw 1.0 mL bacteriostatic water
Inject slowly down vial wall
Gently swirl, do not shake
Refrigerate immediately after mixing
Storage & Shelf Life
Storage & Shelf Life
Lyophilized (unmixed)
Store at −20°C (−4°F) for long-term stability
Short-term storage: 2–8°C (36–46°F) acceptable
Keep dry, sealed, and protected from light
Avoid repeated temperature changes
Reconstituted (mixed)
Store at 2–8°C (36–46°F)
Use within ~30 days for best stability
Do not freeze after mixing
Avoid shaking or agitation
Discard if cloudy, discolored, or particulate matter appears
Best Practice
Handling
Protect from light and keep handling consistent to reduce degradation risk. Limit exposure to air and contamination.
Temperature
Avoid unnecessary room-temperature exposure once mixed. Keep refrigerated between uses and return immediately after drawing doses.
Stability Insight
SS-31 is relatively stable compared to many peptides, but maintaining consistent cold storage helps preserve potency and consistency over time.
Time Between Cycles
Standard Time Between Cycles
Cycle Length4–12 weeks
Time Off2–4 weeks off
Why take a break?
SS-31 is commonly used in defined mitochondrial-support phases. Taking time off allows you to reassess whether continued support is still needed and keeps use more goal-driven.
SS-31 is commonly used in defined mitochondrial-support phases. Taking time off allows you to reassess whether continued support is still needed and keeps use more goal-driven.
When to Stop Sooner
Benefits feel flat or unchanged
The main recovery or mitochondrial support phase has ended
Injection volume or cost becomes too impractical for the current goal
Monitoring During Use
Energy levels and fatigue
Exercise performance
Recovery speed
Cognitive clarity
Benefits
Improved mitochondrial function
Increased ATP production
Reduced oxidative stress
Enhanced recovery and endurance
Neuroprotective support
Cardiometabolic benefits
Potential Side Effects
Mild injection site irritation
Temporary redness or itching
Minimal systemic effects reported
Limited long-term human data
Stacking Strategies
Longevity: SS-31 + MOTS-c
Recovery: SS-31 + BPC-157
Metabolic: SS-31 + NAD+
Important Disclaimer
SS-31 (Elamipretide) is an investigational peptide and not FDA-approved. This content is for educational purposes only.
Comments
Post a Comment